FBLG — FibroBiologics, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1958777 ·
Last close
$0.90
Market Cap
$6.00M
52W High
$9.60
52W Low
$0.62
ADV30
96,800
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -4,033,000 -4,117,000 7,929,000 3,515,000 3,293,000
Mar 2026 0 — -5,068,000 -5,000,000 5,938,000 1,482,000 3,338,000
Dec 2025 0 — -2,590,000 -3,244,000 9,619,000 4,894,000 3,463,000
Sep 2025 0 — -5,038,000 -5,778,000 8,744,000 4,867,000 8,619,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-14,790,000
Investing CF
$-6,000
Financing CF
$9,466,000
CapEx
$-262,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-7.00
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$-63,281,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-17,924,000
Pretax Income TTM
$-18,139,000
Interest Exp TTM
$215,000
Analysts
2

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -16,649,000 -18,646,000 9,619,000 3,463,000 6,156,000 -16,394,000
Dec 2024 0 -13,737,000 -11,161,000 16,445,000 13,710,000 2,735,000 -11,901,000
Dec 2023 0 -8,889,000 -16,485,000 11,821,000 10,568,000 1,253,000 -6,401,000
Dec 2022 0 -4,467,000 -5,121,000 4,824,000 8,820,000 -3,996,000 -4,066,000

TTM Snapshot

Revenues TTM
$133,000
NetIncome TTM
$-18,139,000
OpCashFlow TTM
—
Assets (Latest)
$7,929,000
Forward EPS
$-3.25

Peers — same industry

TickerNameMarket CapLastDaily %
ACXP Acurx Pharmaceuticals, Inc. $6.00M $0.99 —
CNSP CNS Pharmaceuticals, Inc. $6.07M $4.15 —
SNGX SOLIGENIX, INC. $6.11M $0.28 —
INNPF INNOCAN PHARMA Corp $5.80M $1.29 —
GTBP GT Biopharma, Inc. $5.74M $3.18 —

News headlines (Yahoo Finance, 1h cache)

Join FibroBiologics' Live Investor Webinar: Advancing a Fibroblast-Based Cell Therapy Platform Across Multiple High-Value Indications
2026-11-12 14:00 · Yahoo
FibroBiologics Announces Grant of European Patent for Fibroblast Delivery of Tumor Inhibitory Agents
2026-11-05 13:30 · Yahoo
FibroBiologics Presents Preclinical Data on Fibroblast Spheroid-Derived Chondrocyte Spheroids for Degenerative Disc Disease at the North American Spine Society 2026 Annual Meeting
2026-10-19 12:30 · Yahoo
FibroBiologics Announces Australian Patent Accepted for Cellular Blend for the Regeneration of Chondrocytes and Cartilage Cells in Degenerated Spinal Discs
2026-10-14 12:30 · Yahoo
FibroBiologics Files Patent Application for Technology Designed to Produce GLP-1 and Other Therapeutic Peptides Inside the Body
2026-10-07 12:30 · Yahoo
EXCLUSIVE: FibroBiologics Files Patent Application For Cell-Based Alternative to GLP-1 Injections
2026-10-07 12:15 · Yahoo
FibroBiologics Announces Grant of European Patent for Methods of Enhancing Fibroblast Therapeutic Activity
2026-09-29 12:30 · Yahoo
FibroBiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer
2026-09-17 12:30 · Yahoo
FibroBiologics Announces Issuance of New U.S. Patent for the Treatment of Degenerative Disc Disease Using Fibroblast Conditioned Media
2026-09-01 12:30 · Yahoo
FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
2026-08-27 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.